Medication Governance Frameworks for Insurers | IMM

Medication Governance Frameworks for Insurers

Building systematic approaches to medication management that ensure consistency, defensibility, and improved claimant outcomes

Published 3 April 2026

Why You Need Medication Governance

Your claims team makes medication decisions daily. Should we fund this medication? Should we challenge that dose? Should we initiate deprescribing? Without explicit governance frameworks, these decisions vary based on individual adjuster judgment, personal experience, and preference. One adjuster consistently questions opioid prescribing while another funds it routinely. One focuses on deprescribing early while another allows medications to accumulate. Your portfolio experiences inconsistent medication management, which creates vulnerability to challenge and misses optimization opportunities.

Medication governance frameworks solve this problem by establishing explicit policies about medication management expectations, creating consistency across your claims team, providing defensible rationale for funding decisions, and identifying where expert assessment adds value. Good governance isn't restrictive; it's clarifying. Your team understands the framework, applies it consistently, and escalates unusual situations for expert input.

What Medication Governance Includes

A comprehensive medication governance framework addresses these components:

Clear Medication Management Principles

What is your organization's approach to medication management? You might establish principles such as: Evidence-based medication is your default. Medications address diagnosed conditions with documented indication. Doses align with therapeutic guidelines. Deprescribing is part of claims management. Polypharmacy requires explicit clinical justification. These principles guide all medication-related decisions.

Relatedness Guidelines

When is a medication related to injury and should be funded? Your framework should clarify how you assess relatedness, how you handle exacerbated pre-existing conditions, and what documentation supports funding decisions.

Medication Review Triggers

When should you refer for specialist medication review? Your framework identifies specific triggers: claims with five or more medications, medication costs exceeding certain thresholds, benzodiazepine or opioid use, medication combinations with identified interactions, or claimants whose progress has plateaued despite treatment.

Escalation Processes

When medication decisions require expert input? Your framework identifies which decisions adjusters can make independently and which require pharmacist or IME consultation. This prevents both over-escalation (sending routine decisions to expert review) and under-escalation (adjusters making decisions they lack expertise for).

Documentation Standards

What documentation should support medication funding decisions? Your framework specifies what documentation must be present before medications are funded, what documentation justifies non-funding or deprescribing, and what creates defensible decision records.

Good governance frameworks aren't rigid policies that prevent clinical judgment. They're clarifying structures that help your team make consistent, defensible decisions while knowing when to escalate to expert input.

Key Elements of Effective Medication Governance

Build your framework around these core elements:

Element One: Medication Classification System

Classify medications by concern level. Green-light medications are evidence-based, have low cascade risk, and can be funded routinely. Yellow-light medications require closer scrutiny: established benefits but potential concerns about dose, duration, or interactions. Red-light medications require expert assessment: benzodiazepines, high-dose opioids, medications with significant interaction risk. Your classification system helps adjusters know when routine approval is appropriate and when expert input is needed.

Element Two: Dose Guidance

Establish clear dose guidance aligned with therapeutic guidelines. What dose range is evidence-based? What documentation is needed for doses above guideline ranges? Does escalation above certain thresholds require additional approval? Your guidance helps adjusters assess whether dosing is appropriate or requires prescriber discussion.

Element Three: Duration Expectations

Some medications shouldn't continue indefinitely. Benzodiazepines have recommended treatment duration limits. Muscle relaxants have evidence-based duration guidance. Opioids should be reassessed regularly. Your framework clarifies which medications have duration limits and what documentation should exist about reassessment and deprescribing planning.

Element Four: Interaction and Cascade Protocols

What is your approach to polypharmacy and drug interactions? Your framework might specify that claims with five or more medications automatically trigger pharmacist review. Or that specific drug combinations require prescriber documentation of anticipated interactions and monitoring plans. These protocols prevent cascades by making them visible.

Element Five: Deprescribing Expectations

Is deprescribing part of your claim management? Your framework should clarify when deprescribing is expected, who drives deprescribing (your team, your pharmacist, the treating team), how deprescribing failure is addressed, and how you support your claimant through deprescribing processes.

Implementation Components of Your Framework

Effective governance requires more than policy. It requires implementation infrastructure:

Medication Management Guidelines Document

Create a living document that captures your medication management approach. This should address specific medication classes, describe your decision-making process for different scenarios, provide examples of appropriate and inappropriate medications, and explain when expert consultation is needed. Your team should have access to this document and understand how to apply it.

Decision Trees for Common Scenarios

Build decision trees for common medication situations. When opioid is proposed, what's your approval process? When dose escalation exceeds guidelines, what documentation is needed? When deprescribing is recommended, what are success criteria? Decision trees help your team navigate complex scenarios consistently.

Medication Review Protocols

Establish clear protocols for medication review referrals. What triggers a review? What questions should the reviewer address? What timeline is expected? How should recommendations be implemented? Clear protocols ensure medication reviews provide value rather than generating recommendations that sit unimplemented in files.

Auditing and Feedback Mechanisms

Regular audit of medication decisions across your claims team identifies where governance is working and where guidance is needed. If medication decisions are inconsistent across adjusters, your governance needs adjustment. If medication costs are escalating unexpectedly, your framework needs review. Feedback mechanisms help your governance evolve as patterns change.

Specific Governance Policies to Consider

Your framework should address these specific policy areas:

Policy Area Decision to Make Implementation Consideration
Benzodiazepine use Will you fund benzodiazepines? On what terms? Duration limits? Deprescribing requirement? Consider limiting to short-term use with documented deprescribing plan from initiation
Opioid prescribing Will you fund opioids? At what doses? With what monitoring? Duration limits? Consider dose limits aligned with risk, require monitoring plans, support opioid deprescribing
Polypharmacy At what medication count does automatic medication review trigger? Consider 5 or more medications as automatic pharmacist review trigger
Compounding Under what circumstances will you fund compounded medications? Require documented standard failure, clinical rationale, evidence base, and success metrics
Off-label use Will you fund off-label medications? What documentation is needed? Support evidence-based off-label use, require documentation for unusual off-label prescribing
Dose escalation What happens when prescribers exceed guideline dose ranges? Require additional documentation and maybe pharmacist assessment before approving above-guideline doses

Governance and Team Training

Your governance framework only works if your team understands it and can apply it. Investment in training is essential:

  • Initial training when new adjusters join your team, explaining your medication management approach and decision-making process
  • Ongoing training as your framework evolves, ensuring your team stays current with policy changes
  • Case-based learning, reviewing complex medication decisions your team has made and discussing alternative approaches
  • Regular feedback on individual adjuster patterns, helping adjusters understand their decision-making and how it compares to team norms
  • Access to expert consultation when unusual situations arise, supporting your team when they're uncertain
Team engagement: Your governance framework should be collaboratively developed with your claims team, not imposed from above. When adjusters participate in creating governance frameworks, they understand the rationale, buy into the approach, and implement it more consistently. Governance that feels collaborative is more effective than governance that feels restrictive.

Measuring Governance Effectiveness

You should track metrics that show whether your governance is working:

  • Medication cost per claim as benchmark for whether governance is controlling costs
  • Average medications per claim as indicator of whether polypharmacy is being managed
  • Deprescribing success rate showing whether your framework is supporting medication reduction
  • Consistency of medication decisions across adjusters, measured by comparing decisions for similar medication scenarios
  • Claim duration correlated with medication management quality
  • Number of medication review referrals and usefulness of recommendations (are they being implemented?)

These metrics help you assess whether your governance is achieving intended outcomes and where adjustments are needed.

Evolving Your Governance Over Time

Your medication governance framework should evolve as medication landscape, evidence, and your organizational experience change. You should revisit your framework annually or when significant changes occur: new evidence emerges about medication safety or efficacy, medication trends in your claims population shift, your team identifies consistent gaps in the framework, or your organizational strategy changes.

Evolution isn't failure. It's learning. Your governance should get better over time as you learn what works and what needs adjustment.

Expert guidance building your medication governance framework.

IMM can work with your organization to develop medication governance frameworks tailored to your claims profile, your organizational objectives, and your risk management needs. Effective governance improves consistency and reduces medication-related costs across your entire claims portfolio.

Request a Medication Review

This article was prepared by the clinical pharmacy team at IMM (Independent Medication Management), Australia's specialist provider of medication reviews for the insurance industry. IMM works with insurers across workers compensation, CTP, life insurance, and NDIS schemes to deliver pharmacist-led medication management that improves claimant outcomes and reduces medication-related risk. Learn more about IMM's services.

Evidence-Based Medication Oversight for Better Claim Outcomes

Expert pharmacy reviews and medication management services that help claims teams make confident, informed decisions about medication-related claims.

Got Questions? Speak to an Independent Pharmacist

Unbiased advice on your claimant's medications and recovery plan.